ZA864717B - Terguride as a geriatric agent - Google Patents

Terguride as a geriatric agent

Info

Publication number
ZA864717B
ZA864717B ZA864717A ZA864717A ZA864717B ZA 864717 B ZA864717 B ZA 864717B ZA 864717 A ZA864717 A ZA 864717A ZA 864717 A ZA864717 A ZA 864717A ZA 864717 B ZA864717 B ZA 864717B
Authority
ZA
South Africa
Prior art keywords
terguride
geriatric
agent
geriatric agent
doses
Prior art date
Application number
ZA864717A
Other languages
English (en)
Inventor
Bernd Aufdembrinke
Rainer Dorow
Reinhard Horowski
Irmgard Suchy
Gertrud Schroeder
Helmut Wachtel
Wolfgang Kehr
Guenter Stock
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA864717B publication Critical patent/ZA864717B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Led Device Packages (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ZA864717A 1985-06-24 1986-06-24 Terguride as a geriatric agent ZA864717B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853522894 DE3522894A1 (de) 1985-06-24 1985-06-24 Verwendung von tergurid als geriatrikum

Publications (1)

Publication Number Publication Date
ZA864717B true ZA864717B (en) 1987-02-25

Family

ID=6274270

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA864717A ZA864717B (en) 1985-06-24 1986-06-24 Terguride as a geriatric agent

Country Status (11)

Country Link
US (1) US4711891A (fr)
EP (1) EP0207882B1 (fr)
JP (1) JP2618375B2 (fr)
AT (1) ATE146963T1 (fr)
AU (1) AU573448B2 (fr)
CA (1) CA1285880C (fr)
DE (2) DE3522894A1 (fr)
DK (1) DK288786A (fr)
IE (1) IE80545B1 (fr)
IL (1) IL79207A (fr)
ZA (1) ZA864717B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10226459A1 (de) * 2002-06-13 2004-01-08 Neurobiotec Gmbh Verwendung von Dopamin-Partialagonisten zur Behandlung des Restless Legs Syndroms
EP2083008A1 (fr) * 2007-12-07 2009-07-29 Axxonis Pharma AG Dérivés d'ergoline en tant que piégeurs radicaux sélectifs pour les neurones
LU92975B1 (en) * 2016-02-09 2017-08-10 Vivotecc Gmbh Use of Lisuride and Terguride and its 2-Halogen Derivatives for the Treatment as Antipsychotics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH573937A5 (fr) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
EP0021206B1 (fr) * 1979-06-13 1983-06-22 Schering Aktiengesellschaft Dérivés de l'(ergoline-yl)-N', N'-diéthylurée, leur préparation et médicaments les contenant
JPS5732281A (en) * 1980-08-06 1982-02-20 Sumitomo Chem Co Ltd Nitrogen-containing polycyclic compound and its preparation
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
CS231214B1 (en) * 1982-03-12 1984-10-15 Antonin Cerny Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
US4552820A (en) * 1984-04-25 1985-11-12 Lin Data Corporation Disc media

Also Published As

Publication number Publication date
AU5920686A (en) 1987-01-08
IL79207A (en) 1993-04-04
IL79207A0 (en) 1986-09-30
EP0207882A2 (fr) 1987-01-07
DK288786D0 (da) 1986-06-19
IE861663L (en) 1986-12-24
EP0207882A3 (fr) 1990-01-31
AU573448B2 (en) 1988-06-09
IE80545B1 (en) 1998-09-09
CA1285880C (fr) 1991-07-09
US4711891A (en) 1987-12-08
DE3522894A1 (de) 1987-01-02
EP0207882B1 (fr) 1997-01-02
JP2618375B2 (ja) 1997-06-11
DK288786A (da) 1986-12-25
JPS6259211A (ja) 1987-03-14
DE3650590D1 (de) 1997-02-13
ATE146963T1 (de) 1997-01-15

Similar Documents

Publication Publication Date Title
ES2011120A6 (es) Forma de dosificacion para tratar las enfermedades cardiovasculares.
DE3760201D1 (en) (-)-benzhydrylsulfinylacetamide, process for its preparation and its use in therapy
SE8504720L (sv) Ny lekemedelsberedning
EP0345248A3 (fr) Utilisation du cofacteur enzymatique NADPH pour la préparation d'un médicament; le médicament et sa préparation
EP0313654A4 (fr) Medicament pour la prophylaxie et le traitement de l'hepatopathie.
GR900300044T1 (en) Use of monosubstitute selenium compounds in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
DE3572489D1 (en) Indolophenanthridines, their preparation and use
DE3660204D1 (en) Process for the preparation of dichlorotrifluoroethoxy and ethylthioaromatic derivatives
ZA864717B (en) Terguride as a geriatric agent
ZA864610B (en) Use of benzamido-azabicyclo compounds in the treatment of migraine,nausea,vomiting and cardiac arrhythmia
HK182795A (en) Composition useful in the treatment of estrogen deficiencies
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
JPS57181072A (en) Oxaprodine derivative
GR3001277T3 (en) Chlorpheniramine therapy
EP0199085A3 (en) Jomol, its derivatives, process for the preparation of these substances, their use and their production
PH23782A (en) Salt of a substituted morpholine with fluoboric acid and wood preservatives
EP0274425A3 (en) Pyruvate oxidase, its preparation and use
GR3015373T3 (en) 2-Halogen-substituted N-indolyl sulfonic-acid amides, process for their preparation and their pharmaceutical use.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
DE3562997D1 (en) Non-return seal for use in the treatment of wood, process for positioning and closing the seal's bung
ZA861913B (en) Isoxazolidines,process for their preparation,and their use as pest-combating agents
GB2213062A (en) Pharmaceutical preparation having oestrogen action
PT80796A (en) Process for the preparation of solutions of beclometasone 17,21-diprophionate in ether and use thereof
ZA853779B (en) The novel physiologically active substance foroxymithine,a process and microorganisms for its production and its use as medicament
EP0174980A4 (fr) Utilisation d'un composé du manganèse dans la fabrication d'un médicament pour le traitement de l'hypothyroidisme.